Tivic Health Systems Inc (TIVC) is a pioneering medical technology firm focused on developing non-invasive bioelectronic therapies aimed at addressing chronic conditions, particularly allergic rhinitis. Leveraging its proprietary platform and extensive clinical expertise, Tivic Health is committed to delivering innovative solutions that not only meet critical patient needs but also optimize healthcare delivery. Positioned at the vanguard of the burgeoning bioelectronic medicine landscape, the company is set to seize emerging market opportunities, significantly improving patient outcomes and establishing new benchmarks in chronic condition management.
| Revenue (TTM) | 482,000 |
| Gross Profit (TTM) | -280,000 |
| EBITDA | $-7.89M |
| Operating Margin | 0.00% |
| Return on Equity | -82.70% |
| Return on Assets | -28.70% |
| Revenue/Share (TTM) | $0.59 |
| Book Value | $6.65 |
| Price-to-Book | 0.14 |
| Price-to-Sales (TTM) | 1.52 |
| EV/Revenue | 0.563 |
| EV/EBITDA | 0.16 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 15.90% |
| Shares Outstanding | $2.88M |
| Float | $2.53M |
| % Insiders | 1.46% |
| % Institutions | 8.01% |
Volatility is currently expanding